MM+M editors Marc Iskowitz and Larry Dobrow interview people of note in and around the healthcare marketing world, and chat about news impacting the sector. New episodes to be released every Wednesday.
The MM+M Podcast 7.22.21: APCO’s Wayne Pines
The unprecedented nature of the FDA’s approval of Alzheimer’s drug Aduhelm has led to more negative publicity than perhaps any other new medication. Wayne Pines, former FDA official and now president of healthcare at APCO, joins Marc Iskowitz to discuss the implications for the agency’s role in advising pharma companies.
The MM+M Podcast 7.8.21: Otsuka’s Elaine Gamble
As the short list goes live for this year’s MM+M Awards, Otsuka’s Elaine Gamble, chair of judges, debriefs with MM+M’s Marc Iskowitz about her impressions of working with some of the 80-member jury during last month’s virtual judging, as well as general trends she noticed in the entries.
MM+M Podcast with Triple Threat Communications
Tim Frank created Triple Threat Communications more than 15 years ago. Clients soon dubbed it “The Unagency.” So what’s that about, how is it performing, and why might the big network agencies be a bit nervous?”
The future of health must be equitable
Weber Shandwick’s Peter Matheson Gay and United Minds’ Tai Wingfield discuss the role organizations can play in driving progress to close health equity gaps.
The MM+M Podcast 6.24.21: ZS’s Jacob Braude
As COVID-19 vaccination slows in this country, a study finds behavioral nudges may be able to encourage the hesitant to get shots. Jacob Braude, from ZS’s applied behavioral science unit, explains the findings and their commercial applications.
The MM+M Podcast 6.15.21: Unpacking the 2021 Agency 100 issue
With the debut of the Agency 100 issue today, MM+M’s Marc Iskowitz is joined by Stephen Madden, editor-and-chief/GM, and Larry Dobrow, executive editor, to discuss the digital and print content package and what it took to get it done.
MM+M Marketers @ Home 6.10.21: Eli Lilly’s Roni Chase
Roni Chase, VP of marketing at Lilly and an economist by training, explains why real world evidence (RWE) deserves to play a bigger role in pharma’s commercial strategy.
MM+M Podcast with Verywell
As COVID-19 vaccinations roll out and restrictions are lifted, consumers are in a state of transition that impacts mental health in many ways. In this sponsored podcast, therapist and Verywell Editor-in-Chief Amy Morin discusses how attitudes and behaviors are changing, the importance of keeping a finger on the shifts, and how health publishers can better understand and meet consumers’ needs during this long-awaited return to normalcy.
The MM+M Podcast 6.3.21: Juice Pharma’s Forrest King and H&S’s Mario Muredda and Paulette Robinson
Juice Pharma’s Forrest King and Harrison and Star’s Mario Muredda and Paulette Robinson join Marc Iskowitz for the second of a four-part series exploring how MAHF member agencies are progressing toward diversity, equity and inclusion.
MM+M Podcast with Phreesia Life Sciences
The COVID-19 pandemic has had a major impact on patients’ preferences and expectations when it comes to care, and it’s accelerated the move toward consumerism.
MM+M Podcast with GCI Health
The role of work-life balance in the agency world — especially in communications/PR — is often discussed, but why should clients care and why should they seek out agency partners who place a high value on work-life balance for their own teams?
MM+M Podcast with Razorfish Health
Pharmaceutical reps, patients and fellow HCPs are trying to get closer to doctors at a time when they’re driven further apart. A Q4 2020 study conducted by MM+M and RFH revealed unexpected truths for marketers that are now being released in the eBook, The Partnership Paradox.
MM+M podcast with Splice: Episode 3
How Splice’s embrace of individual growth and ‘creativity without walls’ underscores the agency’s employee-first culture.
The MM+M Podcast 5.14.21: IQVIA Institute for Human Data Science’s Murray Aitken
How much of an impact did the pandemic have on medicine spending last year? IQVIA’s Murray Aitken joins MM+M’s Marc Iskowitz to provide a rundown on spend and usage trends, as well as the institute’s outlook for all medicine use through 2025.
MM+M podcast with Swoop
Machine learning and artificial intelligence offer an unprecedented opportunity for pharmaceutical marketing to deliver differentiated messaging to precise patient and HCP audiences on the right channels at the right moment in time.
The MM+M Podcast 5.6.21: Dr. Charlotte Jones-Burton
Dr. Charlotte Jones-Burton, WOCIP president and cofounder, discusses the group’s latest initiative, designed to address vaccine hesitancy among the Black and brown communities by training members of the pharma industry to “demystify” and educate on COVID-19 vaccine clinical trial data.
MM+M podcast with Healthline Media: Episode 2
Heathline Media’s Brendan McHenry discusses complementary health and financial wellness as pillars of the company’s Whole Person Health Initiative.
MM+M podcast with DeepIntent
Surveying patients for a new research report, DeepIntent found that nearly three-quarters of patients believe more lives can be saved if people were better informed about their treatment options — and that many patients don’t feel informed.
The MM+M Podcast 4.28.21: Lisa and Bob Mauriello
Lisa Stockman Mauriello and husband Bob Mauriello, who have been leading a high-profile campaign to gain access to Biogen’s tofersen under so-called expanded access, discuss the drugmaker’s decision this week to make the experimental ALS drug available, but not as soon as they had hoped.
MM+M podcast with Healthline Media
Healthline Media’s Kate Gallagher presents the company’s multi-faceted Whole Person Health Initiative program.
